# OnCo record scibrunch-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/scibrunch-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "scibrunch-therapeutics" ;
  schema:name "SciBrunch Therapeutics"@en ;
  schema:alternateName "Shanghai SciBrunch Therapeutics"@en ;
  schema:description "SciBrunch Therapeutics is a Shanghai company founded in late 2024 that makes pills for hard-to-treat cancers such as pancreatic and bowel cancer. In September 2026 MSD licensed its KRAS G12D drug, a molecular glue not yet tested in people, for USD 400 million upfront; its PARP1 blocker began its first human trial in January 2026."@en ;
  schema:url <https://onco.cc/companies/scibrunch-therapeutics/>, <https://www.scibrunch.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.scibrunch.com/>, <https://www.scibrunch.com/news/6>, <https://www.scibrunch.com/news/4>, <https://www.scibrunch.com/news/1>, <https://www.biospace.com/deals/merck-inks-up-to-2-13b-deal-to-dine-with-scibrunch-gain-rights-to-preclinical-kras-inhibitor> ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/kras-inhibitors/>, <https://onco.cc/technologies/molecular-glue-platforms/>, <https://onco.cc/technologies/parp-inhibitor/> ;
  onco:targets <https://onco.cc/targets/kras/>, <https://onco.cc/targets/parp/> ;
  onco:companies <https://onco.cc/companies/merck/> ;
  onco:trials <https://onco.cc/trials/nct07359066/> .